Xu M - Search Results

1

Advances in the development of N-glycopeptide enrichment materials based on hydrophilic interaction chromatography.

Cheng L, Huang M, Ren H, Wang Y, Cui H, Xu M. Cheng L, et al. Among authors: xu m. Anal Bioanal Chem. 2024 Dec 23. doi: 10.1007/s00216-024-05708-9. Online ahead of print. Anal Bioanal Chem. 2024. PMID: 39710781 Review.

2

Recent development in hydrophilic interaction liquid chromatography stationary materials for glycopeptide analysis.

Liu Z, Xu M, Zhang W, Miao X, Wang PG, Li S, Yang S. Liu Z, et al. Among authors: xu m. Anal Methods. 2022 Nov 18;14(44):4437-4448. doi: 10.1039/d2ay01369j. Anal Methods. 2022. PMID: 36300821 Review.

3

Mass Spectrometric Analysis of Urinary N-Glycosylation Changes in Patients with Parkinson's Disease.

Xu M, Jin H, Ge W, Zhao L, Liu Z, Guo Z, Wu Z, Chen J, Mao C, Zhang X, Liu CF, Yang S. Xu M, et al. ACS Chem Neurosci. 2023 Sep 20;14(18):3507-3517. doi: 10.1021/acschemneuro.3c00404. Epub 2023 Sep 7. ACS Chem Neurosci. 2023. PMID: 37677068

4

Advances in glycopeptide enrichment methods for the analysis of protein glycosylation over the past decade.

Li J, Zhang J, Xu M, Yang Z, Yue S, Zhou W, Gui C, Zhang H, Li S, Wang PG, Yang S. Li J, et al. Among authors: xu m. J Sep Sci. 2022 Aug;45(16):3169-3186. doi: 10.1002/jssc.202200292. Epub 2022 Jul 18. J Sep Sci. 2022. PMID: 35816156 Review.

5

Advances in the development of imaging probes and aggregation inhibitors for alpha-synuclein.

Xu MM, Ryan P, Rudrawar S, Quinn RJ, Zhang HY, Mellick GD. Xu MM, et al. Acta Pharmacol Sin. 2020 Apr;41(4):483-498. doi: 10.1038/s41401-019-0304-y. Epub 2019 Oct 4. Acta Pharmacol Sin. 2020. PMID: 31586134 Free PMC article. Review.

6

Advances in development of fluorescent probes for detecting amyloid-β aggregates.

Xu MM, Ren WM, Tang XC, Hu YH, Zhang HY. Xu MM, et al. Acta Pharmacol Sin. 2016 Jun;37(6):719-30. doi: 10.1038/aps.2015.155. Epub 2016 Mar 21. Acta Pharmacol Sin. 2016. PMID: 26997567 Free PMC article. Review.

7

Protein glycosylation in urine as a biomarker of diseases.

Xu M, Yang A, Xia J, Jiang J, Liu CF, Ye Z, Ma J, Yang S. Xu M, et al. Transl Res. 2023 Mar;253:95-107. doi: 10.1016/j.trsl.2022.08.001. Epub 2022 Aug 8. Transl Res. 2023. PMID: 35952983 Review.

8

Abnormal sialylation and fucosylation of saliva glycoproteins: Characteristics of lung cancer-specific biomarkers.

Gao Z, Xu M, Yue S, Shan H, Xia J, Jiang J, Yang S. Gao Z, et al. Among authors: xu m. Curr Res Pharmacol Drug Discov. 2021 Dec 20;3:100079. doi: 10.1016/j.crphar.2021.100079. eCollection 2022. Curr Res Pharmacol Drug Discov. 2021. PMID: 35005612 Free PMC article. Review.

9

Lung cancer molecular mutations and abnormal glycosylation as biomarkers for early diagnosis.

Yang S, Xia J, Yang Z, Xu M, Li S. Yang S, et al. Among authors: xu m. Cancer Treat Res Commun. 2021;27:100311. doi: 10.1016/j.ctarc.2021.100311. Epub 2021 Jan 13. Cancer Treat Res Commun. 2021. PMID: 33465560 Free article. Review.

10

O-GlcNAcylation of truncated NAC segment alters peptide-dependent effects on α-synuclein aggregation.

Ryan P, Xu MM, Davey AK, Kassiou M, Mellick GD, Rudrawar S. Ryan P, et al. Among authors: xu mm. Bioorg Chem. 2020 Jan;94:103389. doi: 10.1016/j.bioorg.2019.103389. Epub 2019 Nov 9. Bioorg Chem. 2020. PMID: 31753312

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22,417 results

Search Page

Filters